Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the affordable medicines facility-malaria

R Thomson, C Festo, B Johanes, A Kalolella… - PLoS …, 2014 - journals.plos.org
Background The Affordable Medicines Facility-malaria (AMFm) is primarily an artemisinin
combination therapy (ACT) subsidy, aimed at increasing availability, affordability, market …

Changes in the availability and affordability of subsidised artemisinin combination therapy in the private drug retail sector in rural Ghana: before and after the …

EK Ansah, CJM Whitty, C Bart-Plange… - International …, 2016 - academic.oup.com
Background Most people with febrile illness are treated in the private drug retail sector.
Ghana was among nine countries piloting the Global Fund Affordable Medicines Facility …

Insights into the Affordable Medicines Facility-malaria in Ghana: the role of caregivers and licensed chemical sellers in four regions

AA Adjei, P Winch, A Laar, DJ Sullivan, KS Sakyi… - Malaria journal, 2016 - Springer
Abstract Background The Affordable Medicine Facility-malaria (AMFm) was an innovative
global financing mechanism for the provision of quality-assured artemisinin-based …

Access to subsidized ACT and malaria treatment—evidence from the first year of the AMFm program in six districts in Uganda

G Fink, WT Dickens, M Jordan… - Health policy and …, 2014 - academic.oup.com
Objective To determine the effect of the Affordable Medicines Facility for malaria (AMFm)
launched in April 2011 in Uganda on the use of Artemisinin Combination Therapies (ACTs) …

Do price subsidies on artemisinin combination therapy for malaria increase household use?: evidence from a repeated cross-sectional study in remote regions of …

JL Cohen, P Yadav, C Moucheraud, S Alphs… - PloS one, 2013 - journals.plos.org
Background The Affordable Medicines Facility-malaria (AMFm) is a pilot program that uses
price subsidies to increase access to Artemisinin Combination Therapies (ACTs), currently …

Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania

P Yadav, JL Cohen, S Alphs, J Arkedis, PS Larson… - Malaria Journal, 2012 - Springer
Abstract Background The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-
national subsidy program that aims to increase access and affordability of artemisinin …

Experience of healthcare personnel on Co-payment mechanism and the implications on its use in private drug outlets in Uganda

M Ocan, R Bakubi, L Nakalembe, D Ekusai-Sebatta… - Plos one, 2024 - journals.plos.org
Background Malaria treatment is faced with the challenge of access, affordability,
availability, and quality of antimalarial medicines. Affordable medicines facility-malaria …

Trends in access to anti‐malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first‐line anti‐malarials and …

D Kibira, A Ssebagereka, HA van den Ham, J Opigo… - Malaria Journal, 2021 - Springer
Background Malaria is the single largest cause of illness in Uganda. Since the year 2008,
the Global Fund has rolled out several funding streams for malaria control in Uganda …

Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana

A Freeman, A Kwarteng, LG Febir… - … of pharmaceutical policy …, 2017 - Springer
Abstract Background The Affordable Medicines Facility for malaria (AMFm) Program was a
subsidy aimed at artemisinin-based combination therapies (ACTs) in order to increase …

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

AO Talisuna, PG Daumerie, A Balyeku, T Egan, B Piot… - Malaria journal, 2012 - Springer
Background Artemisinin-based combination therapy (ACT), the treatment of choice for
uncomplicated falciparum malaria, is unaffordable and generally inaccessible in the private …